Bevacizumab: Solution for I.V. infusion 100 mg in 4 mL, Solution for I.V. infusion 400 mg in 16 mL; Vegzelma® Page last updated: 5 July 2024 Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 469KB) Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 146KB)